Aurinia Pharmaceuticals Inc. (AUPH)
Market Closed
18 Jun, 20:00
$
16. 46
+0.32
+1.9827%
$
2.03B Market Cap
- P/E Ratio
- Div Yield
1.17M Volume
-0.52 Eps
$ 16.14
Previous Close Want to track AUPH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Aurinia Pharmaceuticals Inc. (AUPH) Statistics
Valuation metrics
Market Cap 2.03B
Enterprise value 2.06B
Trailing P/E (ttm) 7.02
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 6.82
Price/Book (mrq) 3.69
Enterprise Value/Revenue 6.91
Enterprise Value/EBITDA 12.75
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 670.49K
Average volume (90 days) 1.17M
Price summary
52-Week low 7.29
52-Week high 16.88
Beta -
50-Day moving average 15.68
200-Day moving average 15.23
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:50
Last split Date 23 Oct 2013
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 1%
Operating margin 0.42%
Operational effectiveness
Return on assets 0.41%
Return on equity 0.64%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 2.25
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 2.25
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.86
Total debt (mrq) -
Total Debt/Equity (mrq) 0.12
Current ratio (mrq) 5.55%
Book value per share (mrq) 4.29
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
